Biological Information

Background Information:

Androgen receptors are members of a superfamily of nuclear receptors that transduce the effects of a diverse array of small, hydrophobic ligands, including the steroid hormones, thyroid hormone, vitamin D and retinoids.

Family:

NHR

Sub Family:

3-Ketosteroid

Class:

Steroid

Protein Name:

AR

Uniprot Number:

P10275

Protein Aliases:

testicular feminization|Kennedy disease

Gene Name:

AR

Gene ID:

367

Gene Aliases:

AIS|NR3C4|SMAX1|HUMARA

Accession Number:

NM_000044

Organism:

Human

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Binding

Detection Method:

Radiometry

Measured Response:

Scintillation

Testing Information

Procedure Summary:

Human androgen receptors obtained from human LNCaP cells are used in modified HEPES buffer pH 7.4. A 70 µg‡ aliquot is incubated with 0.5 nM [³H]Methyltrienolone for 20 hours at 4°C. Non-specific binding is estimated in the presence of 1 µM Methyltrienolone. Receptors are filtered and washed. The filters are then counted to determine [³H]Methyltrienolone specifically bound. Compounds are screened at 10 µM. ‡The concentration used will be adjusted if necessary.

Ligand:

[³H] Methyltrienolone

Ligand Kd (nM):

0.71

Ligand Concentration:

0.5 nM

Non Specific:

1 µM Testosterone

Incubation:

1200 min at 4°C

Control Inhibitor:

Testosterone

Criteria For Significance:

≥ 50% of max stimulation or inhibition

Test Concentration / Dose:

Suggested concentration for initial testing is 10 uM

Test Sample Requirements:

Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).

Minimum Order Quantity:

2

Turnaround Time

Standard:

15 Business Days

Reference Compound Data

PubChem ID

5757

Name

Estradiol

Measurement

0.01μM - IC50

PubChem ID

6013

Name

Testosterone

Measurement

0.0021μM - IC50

PubChem ID

261000

Name

Methyltrienolone

Measurement

0.00055μM - IC50

Clinical Relevance

Therapeutic Area:

Metabolic Diseases

Adverse / Beneficial Action:

Androgen receptor agonists may promote prostate cancer and cause edema while antagonists may inhibit spermatogenesis and be useful in the treatment of prostate cancer.

Additional Information

Brand:

LeadHunter

Testing Location:

Taiwan - Taipei

RELATED SOLUTIONS

Item: PP16
Item: PP68
Item: PP89
Item: PP116
Item: PP152
Item: PP223
Item: PP241
Item: 302700-0
Item: 302700-1
Item: 302700